【SUNZEN 0148 交流专区】宏诚生科

icy97

Date of change	18 Aug 2017
Name	MADAM OOI BEE HOON
Age	51
Gender	Female
Nationality	Malaysia
Designation	Independent Director
Directorate	Independent and Non Executive
Type of change	Appointment
Qualifications	Higher School Certificate
Working experience and occupation	She has more than 16 years working experience in Telecommunication industry, which involves in the business of whosale of mobile devices and tablets. She is currently a Director of Daily Gain Teleshop Sdn. Bhd. and Best Dg Distributors Sdn. Bhd.
Directorships in public companies and listed issuers (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Direct - 10,400,000 ordinary shares in the Company.Indirect - 6,280,000 ordinary shares in the Company held through by her spouse and children pursuant to Section 59(11)(c) of Companies Act 2016.Direct - 2,000,000 Warrants 2016/2021 in the Company.Indirect - 2,106,000 Warrants 2016/2021 in the Company held through by her spouse pursuant to Section 59(11)(c) of Companies Act 2016.

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR "THE COMPANY")- PROPOSED ACQUISITION OF SHARES IN AMPLIO INGREDIENTS SDN. BHD. BY THE COMPANY
The Board of Directors of Sunzen is pleased to announce that on 8 May 2018 the Company entered into a Sales of Shares Agreement ("SSA") and Shareholders' Agreement ("SA") with Cheong Wai Loon (NRIC No. 801201-14-5741) and Low Yuan Heng (NRIC No. 781205-01-6183) ["Collectively known as "Vendors"] for the acquisition of 700,000 ordinary shares, representing 70% of the total issued share capital of Amplio Ingredients Sdn. Bhd. (Company No. 1045181-W) ("Amplio") for a total Purchase Price of RM2,800,000.00 (Ringgit Malaysia Two Million Eight Hundred Thousand only) ("Purchase Price") ["Proposed Acquisition"]. Upon completion of the Proposed Acquisition, the Company shall own 70% of the shares in Amplio, which shall be a subsidiary of the Company. The full texts of the announcement is attached.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5786961

Attachments Announcement-Acquisition of Shares in Amplio.pdf

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-15052018-00001
Subject	PROPOSED ACQUISITION OF SHARES IN AMPLIO INGREDIENTS SDN. BHD. ("PROPOSED ACQUISITION")
Description	SUNZEN BIOTECH BERHAD ("Sunzen" or " the Company")- PROPOSED ACQUISITION OF SHARES IN AMPLIO INGREDIENTS SDN. BHD.
Query Letter Contents	We refer to your Company’s announcement dated 8 May 2018, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1.        The salient features of the Sales of Shares Agreement and Shareholders' Agreement. 2.        The sources of funding and breakdown of the total purchase price of RM2,800,000. 3.        Sunzen's rights of recourse in the event the profit guarantee is not achieved. 4.        The sources of funding and breakdown of loan sum of RM2,000,000.
Reference is made to the annoucement dated 8 May 2018 and query letter from Bursa Malaysia Berhad dated 15 May 2018 (Ref: IQL-15052018-00001). Please refer to the attachment for further clarification on the Proposed Acquisition of Shares in Amplio Ingredients Sdn. Bhd. This annoucement is dated 16 May 2018.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5791245

Attachments Reply to Bursa Query-Acq of Amplio.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2018	31 Mar 2017	31 Mar 2018	31 Mar 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	70,932	45,745	70,932	45,745
2	Profit/(loss) before tax	-449	1,058	-449	1,058
3	Profit/(loss) for the period	-469	1,051	-469	1,051
4	Profit/(loss) attributable to ordinary equity holders of the parent	-409	1,019	-409	1,019
5	Basic earnings/(loss) per share (Subunit)	-0.09	0.21	-0.09	0.21
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2100

icy97

SUNZEN BIOTECH BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Acquisitions
Details of corporate proposal	ACQUISITION OF 5,250,000 ORDINARY SHARES IN ECOLITE BIOTECH MANUFACTURING SDN BHD ("ECOLITE"), REPRESENTING 70% EQUITY INTEREST IN ECOLITE, FOR A TOTAL PURCHASE CONSIDERATION OF RM12,050,360 TO BE WHOLLY SATISFIED BY THE ISSUANCE AND ALLOTMENT OF 40,848,678 NEW ORDINARY SHARES IN SUNZEN BIOTECH BERHAD ("SUNZEN SHARES") AT AN ISSUE PRICE OF RM0.295 PER SUNZEN SHARE
No. of shares issued under this corporate proposal	40,848,678
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.2950
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	523,421,325
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 75,361,996.700
Listing Date	13 Jun 2018

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

SUNZEN BIOTECH BERHAD

Particulars of Substantial Securities Holder

Name	MR CHUM MUN CUAN
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name & address of registered holder	Chum Mun CuanR3-2-3 Pandan Puteri Condo, Jalan Pandan Indah 6/10 55100 Kuala Lumpur.

Date interest acquired & no of securities acquired
Date interest acquired	12 Jun 2018
No of securities	37,930,915
Circumstances by reason of which Securities Holder has interest	Share Swap arrangement on sale of shares in Ecolite Biotech Manufacturing Sdn. Bhd. in exchange of shares in Sunzen Biotech Berhad
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	37,930,915
Direct (%)	7.25
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	13 Jun 2018
Date notice received by Listed Issuer	13 Jun 2018

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2018	30 Jun 2017	30 Jun 2018	30 Jun 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	51,516	75,876	122,448	121,621
2	Profit/(loss) before tax	2,837	1,426	2,388	2,484
3	Profit/(loss) for the period	2,798	1,527	2,329	2,578
4	Profit/(loss) attributable to ordinary equity holders of the parent	2,580	1,472	2,171	2,491
5	Basic earnings/(loss) per share (Subunit)	0.53	0.31	0.45	0.52
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2100

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR "THE COMPANY")- ACQUISITION OF SHARES IN SUNZEN AGRITECHNOLOGY (NORTHERN) SDN. BHD.
The Board of Directors of Sunzen wishes to announce that its wholly-owned subsidiary, Sunzen Feedtech Sdn. Bhd. (Company No. 782887-K) ("SFSB"), had on 16 October 2018, acquired the remaining 49 ordinary shares representing 49% of the total issued share capital of its 51% owned subsidiary Company namely, Sunzen Agritechnology (Northern) Sdn. Bhd. (Company No. 1238788-V) ("SASB") from Arah Kawasan Sdn. Bhd. (Company No. 353399-M), for a total cash consideration of RM49.00 ("Acquisition of Shares"). Consequent to the Acquisition of Shares, SASB shall become a wholly-owned subsidiary of SFSB, which in turn a wholly-owned subsidiary of Sunzen. SASB was incorporated on 14 July 2017 and its total issued share capital is RM100.00. The principal activity of SASB is manufacturing and trading of biomass materials and fertiliser as well as manufacture and distribution of house brands products. The Acquisition of Shares would not have any material effects on Sunzen Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 December 2018. None of the directors or major shareholders of Sunzen or persons connected with them has any interest, whether direct or indirect in the Acquisition of Shares. Having considered all aspect, the Board of Directors of Sunzen is of the opinion that the Acquisition of Shares is in the best interest of Sunzen. This announcement is dated 16 October 2018.

icy97

Date of change	09 Nov 2018
Name	DATUK HONG CHOON HAU
Age	42
Gender	Male
Nationality	Malaysia
Type of change	Redesignation
Previous Position	Chief Executive Officer
New Position	Managing Director
Directorate	Executive

Qualifications

No

Qualifications

Major/Field of Study

Institute/University

Additional Information

Working experience and occupation
Family relationship with any director and/or major shareholder of the listed issuer
Any conflict of interests that he/she has with the listed issuer
Details of any interest in the securities of the listed issuer or its subsidiaries

Remarks :

Datuk Hong Choon Hau was re-designated from Chief Executive Officer to Group Managing Director cum Group Chief Executive Officer.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2018	30 Sep 2017	30 Sep 2018	30 Sep 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	101,627	78,739	224,075	200,360
2	Profit/(loss) before tax	-1,555	1,403	833	3,887
3	Profit/(loss) for the period	-1,441	953	888	3,531
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,195	874	977	3,365
5	Basic earnings/(loss) per share (Subunit)	-0.24	0.18	0.20	0.70
6	Proposed/Declared dividend per share (Subunit)	0.00	0.30	0.00	0.30
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2100

icy97

Date of change	30 Nov 2018
Name	MR LIM ENG CHAI
Age	48
Gender	Male
Nationality	Malaysia
Designation	Chief Operating Officer
Directorate	Executive
Type of change	Resignation
Reason	Due to Health Issues.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	SUNZEN BIOTECH BERHAD ("Sunzen") or ("the Company")- Acquisition of Property
The Board of Directors of Sunzen wishes to announce that the Company had on 29 January 2019 entered into a Sale and Purchase Agreement (“SPA”) with EA Dutas Sdn. Bhd. (Company No. 1210849-M) of 6879A, Jalan Raja Uda, 12300 Butterworth, Pulau Pinang, to acquire a piece of industrial land held under Title No. GRN 99189, Lot 69279, Mukim Klang, Daerah Klang, Negeri Selangor measuring approximately 4,047 square meters together with with one (1) unit of factory erected thereon (the said land and factory unit shall be referred to as “Property”), for a total cash consideration of RM12,000,000.00, subject to the terms and conditions as set out in the SPA ("Acquisition of Property"). Please refer to the attachment for further details of the Acquisition of Property. This announcement is dated 29 January 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6052557

Attachments Announcement - Acquisition of Property (Attachment) .pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	SUNZEN BIOTECH BERHAD (Sunzen) or (the Company)- Acquisition of Property
Reference is made to the announcement dated 29 January 2019. The Board of Directors of Sunzen wishes to announce that the following sections of the announcement dated 29 January 2019 should read as follows:- 1. INTRODUCTION The Board of Directors of Sunzen wishes to announce that the Company had on 29 January 2019 entered into a Sale and Purchase Agreement (“SPA”) with EA Dutas Sdn. Bhd. [Company No. 1210849-M] of 6879A, Jalan Raja Uda, 123000 Butterworth, Pulau Pinang (“EA Dutas” or “Vendor”), to acquire a piece of industrial land held under Title No. GRN 99189, Lot 69279, Mukim Klang, Daerah Klang, Negeri Selangor measuring approximately 4,047 square meters together with a 3-storey office cum single storey factory building erected thereon (the said land and office cum factory building shall hereinafter be referred to as “Property”), for a total cash consideration of RM12,000,000.00 (“Purchase Price”), subject to the terms and conditions as set out in the SPA (“Acquisition of Property”). 2. DETAILS OF ACQUISITION OF PROPERTY 2.1      Details of the Property Description : Industrial land held under Title No. GRN 99189, Lot 69279, Mukim Klang, Daerah Klang, Negeri Selangor measuring approximately 4,047 square metres together with a 3-storey office cum single storey factory building with built up area of 1,445 square meters and 1,461 square meters respectively erected thereon. Existing and Proposed use : Sunzen is currently renting the Property at  a rental of RM300,000 per annum and is utilising the 3-storey office as the corporate office of Sunzen. The single storey factory  located behind the 3-storey office is utilised as Sunzen warehouse currently. In furtherance to the above, the Board wishes to announce that:- (i) The proposed Acquisition of Property will enable Sunzen to have a saving in rental payment of RM300,000.00 per annum. However, as Sunzen has obtained bank borrowings of RM10,000,000.00 for the proposed Acquisition of Property, there will be a term loan instalment of RM677,268.00 per annum for a tenure of twenty-five (25) years. (ii) The Acquisition of Property is not expected to have material financial impact on Sunzen Group for the financial year ending 31 December 2019. This announcement is dated 14 February 2019.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2018	31 Dec 2017	31 Dec 2018	31 Dec 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	76,354	103,091	300,429	303,451
2	Profit/(loss) before tax	-7,774	125	-6,941	4,012
3	Profit/(loss) for the period	-7,825	109	-6,937	3,640
4	Profit/(loss) attributable to ordinary equity holders of the parent	-7,847	109	-6,870	3,474
5	Basic earnings/(loss) per share (Subunit)	-1.55	0.02	-1.36	0.72
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.30
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2000		0.2100

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR "THE COMPANY")- VALUATION OF NON-CURRENT ASSETS
In accordance with Rule 9.19(46) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Sunzen wishes to inform that Sunzen Corporation Sdn. Bhd., the wholly-owned subsidiary of the Company, has carried out a revaluation on its properties, as detailed hereunder, for the accounting purpose: Property Date of Valuation   Net Carrying Amount as at 31 December 2018 (RM) Market Value as at 27 December 2018 (RM) Surplus/ (Deficit) (RM) GRN 99077, Lot 69289, Mukim and District Klang, State of Selangor Darul Ehsan, bearing postal address No. 13, Jalan Anggerik Mokara 31/47, Kota Kemuning Industrial Park, Seksyen 31, 40460 Shah Alam, Selangor Darul Ehsan 27 December 2018 11,621,489 13,680,000 2,058,511 GRN 99074, Lot 69288, Mukim and District Klang, State of Selangor Darul Ehsan, bearing postal address No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning Industrial Park, Seksyen 31, 40460 Shah Alam, Selangor Darul Ehsan 27 December 2018 12,366,094 13,859,000 1,492,906 Total: 23,987,583 27,539,000 3,551,417 The valuation of the above properties was conducted by Messrs. Raine & Horne International Zaki + Partners Sdn. Bhd. (“Valuer”). The Valuer has inspected the above properties on 27 December 2018. Revaluation Surplus/Deficit The revaluation of the above properties resulted in a surplus of RM3,090,097. The Board of Directors of the Company has approved the incorporation of the revaluation surplus into the financial statements of the Company for the financial year ended 31 December 2018. Effect on Net Assets per share of the Group Based on the audited financial statements of the Company as at 31 December 2017, the revaluation surplus will increase the net asset per share of the Group from RM0.2065 to RM0.2129. Documents available for Inspection The valuation report is available for inspection at the Registered Office of the Company situated at 10th Floor, Menara Hap Seng, No. 1 & 3, Jalan P. Ramlee, 50250 Kuala Lumpur, during normal business hours for a period of 3 months from the date of this announcement. This announcement is dated 28 February 2019.

icy97

Expiry/Maturity of the securities

SUNZEN BIOTECH BERHAD

Instrument Category	Securities of PLC
Instrument Type	Warrants
Type Of Expiry	Expiry/Maturity of the securities
Mode of Satisfaction of Exercise/Conversion price	Cash
Exercise/ Strike/ Conversion Price	Malaysian Ringgit (MYR) 0.1000
Exercise/ Conversion Ratio	1:1
Settlement Type / Convertible into	Physical (Shares)
Last Date & Time of Trading	27 Mar 2019 05:00 PM
Date & Time of Suspension	28 Mar 2019 09:00 AM
Last Date & Time for Transfer into Depositor's CDS a/c	05 Apr 2019 04:00 PM
Date & Time of Expiry	12 Apr 2019 05:00 PM
Date & Time for Delisting	15 Apr 2019 09:00 AM

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6090465

Attachments Notice to Warrantholders - Expiry of Warrants 2014-2019.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2019	31 Mar 2018	31 Mar 2019	31 Mar 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	66,912	70,932	66,912	70,932
2	Profit/(loss) before tax	-1,070	-449	-1,070	-449
3	Profit/(loss) for the period	-943	-469	-943	-469
4	Profit/(loss) attributable to ordinary equity holders of the parent	-961	-409	-961	-409
5	Basic earnings/(loss) per share (Subunit)	-0.19	-0.09	-0.19	-0.09
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2000		0.2000

icy97

SUNZEN BIOTECH BERHAD

Date of change	31 May 2019
Name	MR LIM BOON KUAN
Age	52
Gender	Male
Nationality	Malaysia
Type of change	Resignation
Designation	Chief Financial Officer
Reason	End of Term of Contract

icy97

Date of change	31 May 2019
Name	MR PHANG TONG ENG
Age	55
Gender	Male
Nationality	Malaysia
Type of change	Appointment
Designation	Chief Financial Officer

Qualifications

No Qualifications Major/Field of Study Institute/University Additional Information 1 Professional Qualification Chartered Institute of Management Accountants (CIMA) Systematic Business Training Centre
Working experience and occupation	Mr Phang was attached to Resintech Plastic Sdn Bhd as Accounts Manager for the period from January 1995 to June 1997. Later, in July 1997 he moved to Jets Express Services Sdn Bhd as Finance Manager till November 2007. In February 2008, he joined Sunzen Corporation Sdn Bhd as Finance Manager and was re-designated as Head of Finance and Accounts Division in February 2018.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) RELATED PARTY TRANSACTIONS
Description	SUNZEN BIOTECH BERHAD ("Sunzen" or "the Company")-        Settlement Agreement and Disposal of Shares in Amplio Ingredients Sdn. Bhd.
The Board of Directors of Sunzen wishes to announce that the Company had on 4 July 2019 entered into the following agreements with Low Yuan Heng [NRIC No. 781205-01-6183] (“Purchaser”) and Amplio Ingredients Sdn. Bhd. [Company No. 1045181-W] (“Amplio”), a 70% owned subsidiary of the Company:- Settlement Agreement between Sunzen and the Purchaser (“Settlement Agreement”); Call Option Agreement between Sunzen and Purchaser; Restated Loan Agreement between Sunzen and Amplio; Personal Guarantee from the Purchaser in favour of Sunzen; and Power of attorney from the Purchaser in favour of Sunzen; (collectively referred as “Transaction Documents”), to settle and resolve the controversies and disputes arising from the following agreements and the management and operation of Amplio:- Sale of Shares Agreement entered between Sunzen, Purchaser and Cheong Wai Loon [NRIC No. 801201-14-5741] (“CWL”) dated 8 May 2018; Shareholder’s Agreement entered between Sunzen, Purchaser and CWL dated 8 May 2018; Letter of Guarantee issued by Purchaser and CWL dated 8 May 2018; and Loan Agreement entered between Sunzen and Amplio dated 6 July 2018. Further details of the Settlement Agreement are set out in the attachment. This announcement is dated 4 July 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6213145

Attachments Announcement - Settlement Agreement.pdf